Human Papillomavirus (HPV) Infection Vaccines; Help Protect Against Certain Types of HPV

Human Papillomavirus (HPV) Infection Vaccines are vaccines used to treat or prevent infection by certain types of human papillomavirus. To date, Gardasil, Gardasil 9, and Cervarix are three commercially available HPV vaccines in the market. The safety of the all three vaccines has been well studied.

Gardasil 9 is approved by the Food and Drug Administration (FDA) and can be used for both girls and boys. This vaccine can prevent most cases of cervical cancer if the vaccine is given before girls or women are exposed to the virus. All three HPV infection vaccines has undergone years of extensive safety testing before being licensed by the Food and Drug Administration (FDA).

Human Papillomavirus (HPV) Infection Vaccines is recommended for routine vaccination at age of 11 or 12 years (vaccination can be started at age 9. The Advisory Committee on Immunization Practices (ACIP) recommends vaccination for everyone through age 26 years if not adequately vaccinated previously.

HPV is viral pathogens. It is different than Herpes Simplex Virus (HSV) & Human Immunodeficiency Virus (HIV). HPV is a major cause of throat, mouth, anus, penis, vagina, vulva, and cervical cancer. Various strains of HPV plays an important role in causing most cervical cancer. HPV is a viral infection that is passed between people through skin-to-skin contact. There are more than 100 varieties of human papillomavirus infection.

Of which, around 40 undergo sexual contact and can affect the throat, mouth, or genitals of a human being. Human Papillomavirus (HPV) Infection Vaccines, such as Gardasil 9, is used to treat or prevent vaginal, vulvar, cervical, and anal cancers caused by HPV. Cervical cancer is the fourth most common cancer in women.

Cervical cancer occurs in the cells of the cervix, tissue that connects the uterus and vagina. The HPV vaccine is often called the 'cervical cancer vaccine'. By getting vaccinated against HPV, one can also help protect other people. The more people who are vaccinated in the community, the less the disease will spread. HPV vaccination is for primary prevention of carcinoma cervix.

So far, three Human Papillomavirus (HPV) Infection Vaccines, such as Cervarix (bivalent HPV vaccine), Gardasil (quadrivalent HPV vaccine), & Gardasil9 (9-valent HPV vaccine) have been approved by the U.S FDA. All three HPV vaccines protect against HPV types 16 and 18 that cause most HPV cancers. According to the Centers for Disease Control and Prevention (CDC), two doses of the HPV vaccines are recommended, 6 to 12 months apart.

Third dose is needed if the shots are given less than five months apart. However, there are some mild side effects of the Human Papillomavirus (HPV) Infection Vaccines, such as swelling, redness, or pain in the arm where the shot was given, headache, nausea, dizziness, fever, and muscle or joint pain.

HPV vaccine is recommended for routine vaccination at age 11 or 12 years. CDC’s Advisory Committee on Immunization Practices also recommends vaccination for everyone through age 26 years if not adequately vaccinated when younger. Now, men and women up to age 45 can get vaccinated. US health officials have expanded the recommended age limit for receiving the HPV vaccine to protect against several types of cancer to people in their mid-40s.